Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asia Pacific Heart Rhythm Society (APHRS) scientific statement on stroke prevention strategies in patients with device-detected atrial fibrillation: the 4S-DDAF approach.

The Lancet regional health. Western Pacific·2026
Same author

Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS).

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Development of three-step holistic care pathways to detect and manage comorbidities in patients with atrial fibrillation: the Horizon 2020 EHRA-PATHS consortium.

European heart journal open·2025
Same author

Adverse Effect of Ventricular Rate Regularization Pacing in Biventricular Cardiac Resynchronization Therapy.

Journal of cardiovascular electrophysiology·2025
Same author

Impacts of viral respiratory infections on segments of fatal out-of-hospital cardiac arrests.

Postgraduate medical journal·2025
Same author

Postmortem Removal of Submuscularly Placed Subcutaneous Implantable Cardioverter Defibrillator in the Obese.

Pacing and clinical electrophysiology : PACE·2025
Same journal

Halotolerant plant growth-promoting bacteria <i>Enterobacter</i> sp. Av16 and <i>Acinetobacter</i> sp. Av23 enhance seed germination and seedling photosynthesis of <i>Apocynum pictum</i> under salt stress.

Journal of Zhejiang University. Science. B·2026
Same journal

Integrative analytical and statistical framework for optimization of multiplex qPCR detection of <i>TGFBI</i> mutations in refractive surgery candidates.

Journal of Zhejiang University. Science. B·2026
Same journal

Regenerative potential of Schneiderian membrane-derived mesenchymal stem cells in sinus floor elevation model and calvarial defect model.

Journal of Zhejiang University. Science. B·2026
Same journal

Esculetin attenuates migraine-like pain via CGRP suppression and meningeal mast cell modulation in rat models.

Journal of Zhejiang University. Science. B·2026
Same journal

Cell proliferation and differentiation during epidermis renewal.

Journal of Zhejiang University. Science. B·2026
Same journal

HENMT1: an RNA methyltransferase in biology and disease.

Journal of Zhejiang University. Science. B·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Pacing technology: advances in pacing threshold management.

Chu-pak Lau1, Chung-wah Siu

  • 1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China. cplau@hkucc.hku.hk

Journal of Zhejiang University. Science. B
|July 30, 2010
PubMed
Summary
This summary is machine-generated.

Pacemaker technology has advanced significantly, but device longevity remains a challenge. Modern pacemakers use automatic threshold management algorithms to optimize pacing energy and improve longevity.

More Related Videos

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
08:19

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping

Published on: February 22, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
08:19

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping

Published on: February 22, 2018

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • Pacemaker therapy has evolved over five decades with sophisticated features.
  • Device longevity is a persistent challenge in pacemaker design since 1958.
  • Hardware and software solutions aim to enhance pacemaker longevity and minimize energy use.

Purpose of the Study:

  • To review the current state-of-the-art in pacing threshold management for modern pacemakers.
  • To discuss the role of automatic threshold management algorithms.
  • To address the need for fully automatic pacing systems in clinical practice.

Main Methods:

  • Review of current literature on pacemaker technology and threshold management.
  • Analysis of software-based solutions for energy optimization.
  • Examination of automatic threshold management algorithms introduced by manufacturers.

Main Results:

  • Significant advancements in pacemaker technology have been made.
  • Device longevity remains a critical design consideration.
  • Automatic threshold management algorithms are increasingly adopted to optimize pacing.

Conclusions:

  • Modern pacemakers incorporate advanced features to improve performance and longevity.
  • Automatic threshold management is a key development in optimizing pacing energy and safety.
  • Continued innovation in pacemaker design is crucial for addressing device longevity challenges.